Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  lung cancer
Stage/Subtype:  lung cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-14 of 14 for your search:
Start Over
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Status: Active
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NLG0301, NCI-2013-00592, 1209-1184, NCT01774578
Vaccine Therapy in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 11-094, NCI-2013-00081, NCT01720836
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, 348360, P131392, NCT02054104
Genetically Modified T Cells in Treating Patients with Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2727.00, NCI-2015-00329, 2727, NCT02408016
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NLG0401, NCI-2016-00186, 1504-1393, NCT02460367
Vaccine Therapy in Treating Patients with Non-small Cell Lung Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-004, NCI-2014-01874, UPCI 08-004, NCT00793208
Vaccine Therapy and Celecoxib in Treating Patients with Lung Cancer, Esophageal Cancer, Thymic Cancers, Thoracic Sarcomas, or Malignant Pleural Mesotheliomas Undergoing Surgery
Status: Temporarily closed
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 11-C-0041, NCI-2013-01472, 110041, P09574, NCT01258868
Vaccine Therapy in Treating Patients with HER2-Positive Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-C-0016, NCI-2013-01564, 130016, P12990, NCT01730118
Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: ID-LV305-2013-001, NCI-2014-01153, NCT02122861
INO-1400 Vaccine Alone or in Combination with INO-9012 Followed by Electroporation in Treating Patients with Breast, Lung, or Pancreatic Cancer at High Risk of Relapse after Surgery and Standard Treatment
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC #22913 / Inovio TRT-00, NCI-2015-00389, 821038, UPCC 22913, NCT02327468
Vaccine Therapy and Pembrolizumab in Treating Patients with Solid Tumors That Have Failed Prior Therapy
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15002, NCI-2015-00653, 116634, 122284, 122771, 124524, NCT02432963
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI-DSP7888-101, NCI-2015-01357, NCT02498665
Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CR107667, NCI-2015-02101, 64041757LUC1001, NCT02592967
Start Over